The cost-effectiveness of therapies to treat alcohol use disorders

被引:18
|
作者
Rehm, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Barbosa, C. [8 ]
机构
[1] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada
[2] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Dalla Lana Sch Publ Hlth, Addict Policy, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany
[7] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies CELOS, Dresden, Germany
[8] RTI Int, Behav Hlth & Criminal Justice Div, Chicago, IL USA
关键词
Alcohol; alcohol use disorders; therapy; behavioral intervention; pharmaceutical intervention; brief intervention; cost-effectiveness; cost-benefit analysis; economic analysis; PRIMARY-HEALTH-CARE; COGNITIVE-BEHAVIORAL THERAPY; BRIEF INTERVENTIONS; GLOBAL BURDEN; TREATMENT SBIRT; DOUBLE-BLIND; DEPENDENCE; CONSUMPTION; MISUSE; ACAMPROSATE;
D O I
10.1080/14737167.2018.1392241
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Introduction: Alcohol use is a major risk factor for mortality and morbidity burden, and alcohol use disorders contribute markedly to this burden. Effective interventions for alcohol use disorders improve health, and are potentially cost-effective or even cost saving. Areas covered: We searched the literature for the cost-effectiveness of alcohol interventions. We included behavioral, pharmacological and combined interventions, and research from both a health care provider and a societal perspective. Overall, many economic research studies pointed towards existing cost-beneficial therapies from the perspective of a health care provider; i.e. the costs for interventions were smaller than the savings in services delivery in the years thereafter. Even if this was not the case, the interventions proved to be cost-effective with a threshold below $ 20,000 per quality-adjusted life year. Expert Commentary: While most of the economic research to date shows promising results, such research is relatively scarce and not always rigorous. More, and more rigorous economic research is needed to fully understand the potential impact of alcohol interventions. However, even with this research, something needs to be done to reduce stigmatization of alcohol use disorders in order to fully reap the benefits of alcohol interventions.
引用
收藏
页码:43 / 49
页数:7
相关论文
共 50 条
  • [31] The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders
    Wyatt, K.
    Henley, W.
    Anderson, L.
    Anderson, R.
    Nikolaou, V.
    Stein, K.
    Klinger, L.
    Hughes, D.
    Waldek, S.
    Lachmann, R.
    Mehta, A.
    Vellodi, A.
    Logan, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (39) : V - +
  • [32] THE COST-EFFECTIVENESS OF TREATING HYPERCHOLESTEROLEMIA - WHOM TO TREAT WITH WHAT
    KINOSIAN, B
    EISENBERG, JM
    MEDICAL DECISION MAKING, 1986, 6 (04) : 275 - 275
  • [33] Cost-Effectiveness of Therapeutic Hypothermia to Treat Neonatal Encephalopathy
    Regier, Dean A.
    Petrou, Stavros
    Henderson, Jane
    Eddama, Oya
    Patel, Nishma
    Strohm, Brenda
    Brocklehurst, Peter
    Edwards, A. David
    Azzopardi, Denis
    VALUE IN HEALTH, 2010, 13 (06) : 695 - 702
  • [34] COST-EFFECTIVENESS OF CHOLESTYRAMINE - WHO SHOULD WE TREAT
    OSTER, G
    EPSTEIN, AM
    CLINICAL RESEARCH, 1986, 34 (02): : A379 - A379
  • [35] Cost-effectiveness strategies to treat osteoporosis in elderly women
    Pfister, Alfred K.
    Welch, Christine A.
    Lester, Melissa D.
    Emmett, Mary K.
    Saville, Paul D.
    Duerring, Shea A.
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (02) : 123 - 131
  • [36] Cost-effectiveness of a primary care intervention to treat obesity
    A G Tsai
    T A Wadden
    S Volger
    D B Sarwer
    M Vetter
    S Kumanyika
    R I Berkowitz
    L K Diewald
    J Perez
    J Lavenberg
    E R Panigrahi
    H A Glick
    International Journal of Obesity, 2013, 37 : S31 - S37
  • [37] Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
    Watt, Maureen
    Dinh, Aur Elien
    Le Monnier, Alban
    Tilleul, Patrick
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 678 - 686
  • [38] Cost-effectiveness of a primary care intervention to treat obesity
    Tsai, A. G.
    Wadden, T. A.
    Volger, S.
    Sarwer, D. B.
    Vetter, M.
    Kumanyika, S.
    Berkowitz, R. I.
    Diewald, L. K.
    Perez, J.
    Lavenberg, J.
    Panigrahi, E. R.
    Glick, H. A.
    INTERNATIONAL JOURNAL OF OBESITY, 2013, 37 : S31 - S37
  • [39] To treat or not to treat: Intracranial hemorrhage, immune globulin effectiveness, and cost-effectiveness in pediatric ITP.
    Adams, JR
    Tarantino, MS
    DiLiberti, JH
    Bennett, CL
    BLOOD, 2001, 98 (11) : 863A - 863A
  • [40] A MODEL TO EVALUATE THE COST-EFFECTIVENESS OF ORAL THERAPIES IN THE MANAGEMENT OF PATIENTS WITH MAJOR DEPRESSIVE-DISORDERS
    EINARSON, TR
    ARIKIAN, S
    SWEENEY, S
    DOYLE, J
    CLINICAL THERAPEUTICS, 1995, 17 (01) : 136 - 153